151 related articles for article (PubMed ID: 1334372)
1. Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.
Iwahana H; Yoshimoto K; Shigekiyo T; Shirakami A; Saito S; Itakura M
Am J Hum Genet; 1992 Dec; 51(6):1386-95. PubMed ID: 1334372
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of a compound heterozygote for hypoprothrombinemia and dysprothrombinemia (-G 7248/7249 and ARG 340 TRP).
Tamary H; Surrey S; Augustine J; Shalmon L; Schwartz E; Rappaport EF
Blood Coagul Fibrinolysis; 1997 Sep; 8(6):337-43. PubMed ID: 9351523
[TBL] [Abstract][Full Text] [Related]
3. Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia.
Iwahana H; Yoshimoto K; Shigekiyo T; Shirakami A; Saito S; Itakura M
Int J Hematol; 1992 Feb; 55(1):93-100. PubMed ID: 1349838
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.
O'Marcaigh AS; Nichols WL; Hassinger NL; Mullins JD; Mallouh AA; Gilchrist GS; Owen WG
Blood; 1996 Oct; 88(7):2611-8. PubMed ID: 8839854
[TBL] [Abstract][Full Text] [Related]
5. A new variant of human prothrombin: prothrombin Metz, demonstration in a family showing double heterozygosity for congenital hypoprothrombinemia and dysprothrombinemia.
Josso F; Rio Y; Béguin S
Haemostasis; 1982; 12(4):309-16. PubMed ID: 7152370
[TBL] [Abstract][Full Text] [Related]
6. Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency.
Akhavan S; Mannucci PM; Lak M; Mancuso G; Mazzucconi MG; Rocino A; Jenkins PV; Perkins SJ
Thromb Haemost; 2000 Dec; 84(6):989-97. PubMed ID: 11154146
[TBL] [Abstract][Full Text] [Related]
7. Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency.
Poort SR; Landolfi R; Bertina RM
Thromb Haemost; 1997 Apr; 77(4):610-5. PubMed ID: 9134629
[TBL] [Abstract][Full Text] [Related]
8. Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia.
Henriksen RA; Dunham CK; Miller LD; Casey JT; Menke JB; Knupp CL; Usala SJ
Blood; 1998 Mar; 91(6):2026-31. PubMed ID: 9490687
[TBL] [Abstract][Full Text] [Related]
9. Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His).
Morishita E; Saito M; Kumabashiri I; Asakura H; Matsuda T; Yamaguchi K
Blood; 1992 Nov; 80(9):2275-80. PubMed ID: 1421398
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genetic analysis of a compound heterozygote for dys- and hypoprothrombinaemia.
Akhavan S; Luciani M; Lavoretano S; Mannucci PM
Br J Haematol; 2003 Jan; 120(1):142-4. PubMed ID: 12492590
[TBL] [Abstract][Full Text] [Related]
11. Congenital prothrombin deficiency.
Lancellotti S; De Cristofaro R
Semin Thromb Hemost; 2009 Jun; 35(4):367-81. PubMed ID: 19598065
[TBL] [Abstract][Full Text] [Related]
12. A common mutation, Arg457-->Gln, links prothrombin deficiencies in the Puerto Rican population.
Lefkowitz JB; Weller A; Nuss R; Santiago-Borrero PJ; Brown DL; Ortiz IR
J Thromb Haemost; 2003 Nov; 1(11):2381-8. PubMed ID: 14629473
[TBL] [Abstract][Full Text] [Related]
13. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia.
Sun WY; Smirnow D; Jenkins ML; Degen SJ
Thromb Haemost; 2001 Apr; 85(4):651-4. PubMed ID: 11341500
[TBL] [Abstract][Full Text] [Related]
14. Prothrombin San Antonio: a single amino acid substitution at a factor Xa activation site (Arg320 to His) results in dysprothrombinemia.
Sun WY; Burkart MC; Holahan JR; Degen SJ
Blood; 2000 Jan; 95(2):711-4. PubMed ID: 10627484
[TBL] [Abstract][Full Text] [Related]
15. Two novel mutations in the prothrombin gene cause severe bleeding in a compound heterozygous patient.
Poort SR; Njo KT; Vos HL; Bertina RM
Blood Coagul Fibrinolysis; 1998 Nov; 9(8):761-4. PubMed ID: 9890721
[TBL] [Abstract][Full Text] [Related]
16. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
Huber S; McMaster KJ; Voelkerding KV
J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
[TBL] [Abstract][Full Text] [Related]
17. Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly.
Wang W; Fu Q; Zhou R; Wu W; Ding Q; Hu Y; Wang X; Wang H; Wang Z
Haemophilia; 2004 Jan; 10(1):94-7. PubMed ID: 14962227
[TBL] [Abstract][Full Text] [Related]
18. [Prothrombin deficiency resulted from a homozygous Glu29 to Gly mutation in the prothrombin gene].
Wang WB; Wang HL; Huang CY; Fang Y; Fu QH; Zhou RF; Xie S; Ding QL; Wu WM; Wang XF; Hu YQ; Wang ZY
Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):449-51. PubMed ID: 14575584
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genetic analysis of dysprothrombinemia due to a novel homozygous mutation.
Su K; Jin Y; Miao Z; Cheng X; Yang L; Wang M
Hematology; 2017 Jul; 22(6):380-385. PubMed ID: 28196451
[TBL] [Abstract][Full Text] [Related]
20. Homozygosity for a novel missense mutation in the prothrombin gene causing a severe bleeding disorder.
Poort SR; Michiels JJ; Reitsma PH; Bertina RM
Thromb Haemost; 1994 Dec; 72(6):819-24. PubMed ID: 7740448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
